In light of continued progress and improved COVID-19 metrics reported by the NCDHHS, we are now providing patients with the opportunity to be seen face to face. The option for virtual services remains; however, initial and annual assessments/evaluations must be provided in the clinic. Please note, face coverings are required for all in-clinic services and CDC guidelines must be adhered.
WE ARE CURRENTLY EXPERIENCING PHONE ISSUES WHEN CALLS ARE COMING FROM REGULAR (LANDLINE) PHONES. IF YOU CANNOT GET THROUGH TO OUR OFFICE, PLEASE TRY CALLING USING A CELL PHONE, THANK YOU
Kelly House is a therapeutic home for women with substance use disorders who are pregnant or have infants up to six months old. It is a safe, structured, home-like environment where the journey to recovery begins.
Kelly House residents participate in treatment specifically designed to meet the unique needs and issues of a mother or expectant mother in recovery.
Individualized treatment at Kelly House includes:
Case Management Services are available to each woman to assist her in maximizing self-sufficiency. Clinical staff will assist in linking with community resources and prenatal medical care, well-baby check-ups and any other medical care required.
Kelly House is named in honor of Mary Kelly, a substance abuse professional who has dedicated her life’s work to advocating for people seeking to recover from substance abuse – especially women. Mary is now retired but still remains proactive on behalf of the recovering community.
The Kelly House program is available for those that meet the following criteria:
Referrals are accepted from a wide variety of agencies including:
Priority admission to the Kelly House program is given to:
In accordance with 45 CFR §96.131 Treatment Services for Pregnant Women of the Substance Abuse Prevention & Treatment Block Grant, pregnant women are given preference in admissions to this program/facility. Priority admission is as follows: (1) Pregnant women using substances intravenously, (2) Pregnant women with a substance use disorder, (3) Women using substances intravenously, (4) All others.